Affymax(R) to Host Teleconference/Webcast on Monday, July 16, 2007, to Review Hematide(TM) Clinical Development Program.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Affymax, Inc. (Nasdaq:AFFY Af`fy´ v. t. 1. To confide (one's self to, or in); to trust. [ imp. & p. p. os> ( ) r>; p. pr. os> 2. To betroth or espouse; to affiance. 3. ) will host a teleconference and webcast on Monday, July 16, 2007, at 10:00 a.m. Eastern time to review its Hematide[TM] clinical development program. Hematide is the company's lead drug in development for the treatment of anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin . Interested parties can listen to the live call by dialing (800) 810-0924 from the U.S. or (913) 981-4900 internationally. There also will be a live and archived webcast that can be accessed by visiting www.affymax.com and going to the Investors section. A telephone replay will be available for seven days following the conclusion of the call by dialing (888) 203-1112 from the U.S. or (719) 457-0820 for international callers and entering passcode 2846279. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide[TM], is currently in Phase 2 clinical trials phase 2 clinical trial Phase 2 study. See Phase study. for the treatment of anemia associated with chronic kidney disease Chronic kidney disease (CKD), also know as chronic renal disease, is a progressive loss of renal function over a period of months or years through five stages. Each stage is a progression through an abnormally low and progressively worse glomerular filtration rate, which is and cancer. For additional information, please visit www.affymax.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion